vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $38.3M, roughly 2.0× ImmunityBio, Inc.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -161.8%, a 170.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 10.6%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
BFS vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $38.3M |
| Net Profit | $6.5M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 65.4% | -169.0% |
| Net Margin | 8.7% | -161.8% |
| Revenue YoY | 10.6% | 407.0% |
| Net Profit YoY | -19.6% | -4.7% |
| EPS (diluted) | $0.15 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $38.3M | ||
| Q3 25 | $72.0M | $32.1M | ||
| Q2 25 | $70.8M | $26.4M | ||
| Q1 25 | $71.9M | $16.5M | ||
| Q4 24 | $67.9M | $7.6M | ||
| Q3 24 | $67.3M | $6.1M | ||
| Q2 24 | $66.9M | — | ||
| Q1 24 | $66.7M | — |
| Q4 25 | $6.5M | $-61.9M | ||
| Q3 25 | $10.5M | $-67.3M | ||
| Q2 25 | $10.7M | $-92.6M | ||
| Q1 25 | $9.8M | $-129.6M | ||
| Q4 24 | $8.1M | $-59.2M | ||
| Q3 24 | $14.5M | $-85.7M | ||
| Q2 24 | $14.4M | — | ||
| Q1 24 | $13.6M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | 65.4% | -169.0% | ||
| Q3 25 | 69.1% | -173.5% | ||
| Q2 25 | 68.7% | -269.8% | ||
| Q1 25 | 66.5% | -390.1% | ||
| Q4 24 | 82.9% | -919.0% | ||
| Q3 24 | 72.8% | -1314.3% | ||
| Q2 24 | 75.0% | — | ||
| Q1 24 | 72.4% | — |
| Q4 25 | 8.7% | -161.8% | ||
| Q3 25 | 14.6% | -209.8% | ||
| Q2 25 | 15.1% | -350.3% | ||
| Q1 25 | 13.6% | -784.9% | ||
| Q4 24 | 11.9% | -783.4% | ||
| Q3 24 | 21.5% | -1404.0% | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | $0.15 | $-0.06 | ||
| Q3 25 | $0.32 | $-0.07 | ||
| Q2 25 | $0.33 | $-0.10 | ||
| Q1 25 | $0.29 | $-0.15 | ||
| Q4 24 | $0.22 | $-0.08 | ||
| Q3 24 | $0.48 | $-0.14 | ||
| Q2 24 | $0.48 | — | ||
| Q1 24 | $0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $242.8M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $-500.5M |
| Total Assets | $2.2B | $501.9M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $242.8M | ||
| Q3 25 | $11.8M | $257.8M | ||
| Q2 25 | $5.3M | $153.7M | ||
| Q1 25 | $6.5M | $61.6M | ||
| Q4 24 | $10.3M | $149.8M | ||
| Q3 24 | $7.2M | $130.4M | ||
| Q2 24 | $6.9M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $455.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $307.8M | $-500.5M | ||
| Q3 25 | $316.6M | $-524.3M | ||
| Q2 25 | $322.4M | $-570.7M | ||
| Q1 25 | $328.4M | $-591.4M | ||
| Q4 24 | $335.8M | $-489.1M | ||
| Q3 24 | $341.8M | $-745.1M | ||
| Q2 24 | $345.7M | — | ||
| Q1 24 | $347.1M | — |
| Q4 25 | $2.2B | $501.9M | ||
| Q3 25 | $2.2B | $519.0M | ||
| Q2 25 | $2.1B | $402.1M | ||
| Q1 25 | $2.1B | $303.8M | ||
| Q4 24 | $2.1B | $382.9M | ||
| Q3 24 | $2.1B | $364.6M | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.0B | — |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $-70.4M | ||
| Q3 25 | $20.6M | $-68.9M | ||
| Q2 25 | $26.6M | $-79.7M | ||
| Q1 25 | $30.4M | $-85.9M | ||
| Q4 24 | $121.2M | $-85.1M | ||
| Q3 24 | $26.5M | $-98.8M | ||
| Q2 24 | $32.1M | — | ||
| Q1 24 | $33.8M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | $-28.3M | $-101.6M | ||
| Q2 24 | $-12.5M | — | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | -42.1% | -1663.2% | ||
| Q2 24 | -18.7% | — | ||
| Q1 24 | -17.6% | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | 81.5% | 45.7% | ||
| Q2 24 | 66.7% | — | ||
| Q1 24 | 68.3% | — |
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
